These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34912784)

  • 1. Sensitive LC-MS/MS Methods for Amphotericin B Analysis in Cerebrospinal Fluid, Plasma, Plasma Ultrafiltrate, and Urine: Application to Clinical Pharmacokinetics.
    Pippa LF; Marques MP; da Silva ACT; Vilar FC; de Haes TM; da Fonseca BAL; Martinez R; Coelho EB; Wichert-Ana L; Lanchote VL
    Front Chem; 2021; 9():782131. PubMed ID: 34912784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma protein binding of amphotericin B and pharmacokinetics of bound versus unbound amphotericin B after administration of intravenous liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate.
    Bekersky I; Fielding RM; Dressler DE; Lee JW; Buell DN; Walsh TJ
    Antimicrob Agents Chemother; 2002 Mar; 46(3):834-40. PubMed ID: 11850269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilizing online-dual-SPE-LC with HRMS for the simultaneous quantification of amphotericin B, fluconazole, and fluorocytosine in human plasma and cerebrospinal fluid.
    Qu L; Qian J; Ma P; Yin Z
    Talanta; 2017 Apr; 165():449-457. PubMed ID: 28153282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics of amphotericin B in the cerebrospinal fluid during continuous intrathecal administration for treatment of cryptococcal neoformans meningitis].
    Fang M; Lv TM; Yan Y; Liu ST; Gao WH; Liu XJ; Yin J; Wang L; Wang YY
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Nov; 31(11):1929-31. PubMed ID: 22126783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring and impact of fluconazole serum and cerebrospinal fluid concentration in HIV-associated cryptococcal meningitis-infected patients.
    Manosuthi W; Chetchotisakd P; Nolen TL; Wallace D; Sungkanuparph S; Anekthananon T; Supparatpinyo K; Pappas PG; Larsen RA; Filler SG; Andes D;
    HIV Med; 2010 Apr; 11(4):276-81. PubMed ID: 20002501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determine the pharmacokinetics (half-life, volume of distribution and clearance) of AMB-FUBINACA in rats plasma using GC-MS / MS.
    Abdelgadir EH; Alshehri SD; Kumar S
    J Pharmacol Toxicol Methods; 2024; 127():107513. PubMed ID: 38729531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of furosemide and its glucuronide metabolite in plasma, plasma ultrafiltrate and urine by HPLC-MS/MS with application to secretion and metabolite formation clearances in non-pregnant and pregnant women.
    Benzi JRL; Rocha A; Colombari JC; Pego AMG; Dos Santos Melli PP; Duarte G; Lanchote VL
    J Pharm Biomed Anal; 2023 Oct; 235():115635. PubMed ID: 37634358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma protein distribution and its impact on pharmacokinetics of liposomal amphotericin B in paediatric patients with malignant diseases.
    Hong Y; Shaw PJ; Tattam BN; Nath CE; Earl JW; Stephen KR; McLachlan AJ
    Eur J Clin Pharmacol; 2007 Feb; 63(2):165-72. PubMed ID: 17180621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics, excretion, and mass balance of liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate in humans.
    Bekersky I; Fielding RM; Dressler DE; Lee JW; Buell DN; Walsh TJ
    Antimicrob Agents Chemother; 2002 Mar; 46(3):828-33. PubMed ID: 11850268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of daunorubicin and its metabolite daunorubicinol in plasma and urine with application in the evaluation of total, renal and metabolic formation clearances in patients with acute myeloid leukemia.
    Oliveira ML; Rocha A; Nardotto GHB; Pippa LF; Simões BP; Lanchote VL
    J Pharm Biomed Anal; 2020 Nov; 191():113576. PubMed ID: 32889347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis.
    Loyse A; Wilson D; Meintjes G; Jarvis JN; Bicanic T; Bishop L; Rebe K; Williams A; Jaffar S; Bekker LG; Wood R; Harrison TS
    Clin Infect Dis; 2012 Jan; 54(1):121-8. PubMed ID: 22052885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amphotericin B transfer to CSF following intravenous administration of liposomal amphotericin B.
    Strenger V; Meinitzer A; Donnerer J; Hofer N; Dornbusch HJ; Wanz U; Seidel MG; Sperl D; Lackner H; Schwinger W; Sovinz P; Benesch M; Urban C
    J Antimicrob Chemother; 2014 Sep; 69(9):2522-6. PubMed ID: 24891430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioanalysis of free and liposomal Amphotericin B in rat plasma using solid phase extraction and protein precipitation followed by LC-MS/MS.
    Su C; Yang H; Sun H; Fawcett JP; Sun D; Gu J
    J Pharm Biomed Anal; 2018 Sep; 158():288-293. PubMed ID: 29902693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of amphotericin B lipid complex in critically ill patients undergoing continuous venovenous haemodiafiltration.
    Malone ME; Corrigan OI; Kavanagh PV; Gowing C; Donnelly M; D'Arcy DM
    Int J Antimicrob Agents; 2013 Oct; 42(4):335-42. PubMed ID: 23920093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic evaluation of amphotericin B in lung tissue: lung lymph distribution after intravenous injection and airspace distribution after aerosolization and inhalation of amphotericin B.
    Koizumi T; Kubo K; Kaneki T; Hanaoka M; Hayano T; Miyahara T; Okada K; Fujimoto K; Yamamoto H; Kobayashi T; Sekiguchi M
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1597-600. PubMed ID: 9660990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings.
    Sloan D; Dlamini S; Paul N; Dedicoat M
    Cochrane Database Syst Rev; 2008 Oct; (4):CD005647. PubMed ID: 18843697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A versatile high-performance LC-MS/MS assay for the quantification of voriconazole and its N-oxide metabolite in small sample volumes of multiple human matrices for biomedical applications.
    Schulz J; Michelet R; Joseph JF; Zeitlinger M; Schumacher F; Mikus G; Kloft C
    J Pharm Biomed Anal; 2022 Feb; 210():114551. PubMed ID: 34999435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma and cerebrospinal fluid pharmacokinetics of intravenous oxaliplatin, cisplatin, and carboplatin in nonhuman primates.
    Jacobs SS; Fox E; Dennie C; Morgan LB; McCully CL; Balis FM
    Clin Cancer Res; 2005 Feb; 11(4):1669-74. PubMed ID: 15746072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of free and total amphotericin B in human biologic matrices by a liquid chromatography tandem mass spectrometric method.
    Lee JW; Petersen ME; Lin P; Dressler D; Bekersky I
    Ther Drug Monit; 2001 Jun; 23(3):268-76. PubMed ID: 11360037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of bupivacaine enantiomers in plasma as total and unbound concentrations using LC-MS/MS: Application in a pharmacokinetic study of a parturient with placental transfer.
    Souza MCO; Marques MP; Duarte G; Lanchote VL
    J Pharm Biomed Anal; 2019 Feb; 164():268-275. PubMed ID: 30399533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.